Capula Management LTD Dexcom Inc Transaction History

Capula Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $270,259 - $338,828	-2,081 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $194,959 - $261,589	1,827 Added 719.29%	2,081 $1.14 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $20,571 - $27,414	254 New	254 $108,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.